NasdaqGS - Nasdaq Real Time Price USD
Recursion Pharmaceuticals, Inc. (RXRX)
3.2300 +0.0700 (+2.22%)
At close: June 24 at 4:00:01 PM EDT
3.2300 0.0000 (0.00%)
Overnight: 10:33:31 PM EDT
This price reflects trading activity during the overnight session on the Blue Ocean ATS, available 8 PM to 4 AM ET, Sunday through Thursday, when regular markets are closed.
Trade RXRX on Coinbase
Trading disclosure
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for certain activity generated through this link. Prices displayed are informational.
Learn moreChart Range Bar
Loading chart for RXRX
Chart does not reflect overnight price.
- Previous Close
3.1600 - Open
3.1950 - Bid 2.8800 x 200
- Ask 4.0900 x 200
- Day's Range
3.1601 - 3.3800 - 52 Week Range
2.7700 - 7.1800 - Volume
15,389,642 - Avg. Volume
15,808,930 - Market Cap (intraday)
1.714B - Beta (5Y Monthly) 1.00
- PE Ratio (TTM)
-- - EPS (TTM)
-1.1900 - Earnings Date (est.) Aug 5, 2026
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
6.64
Recent News
View More
Performance Overview
Trailing total returns as of 6/24/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .
YTD Return
RXRX
21.03%
S&P 500 (^GSPC)
7.49%
1-Year Return
RXRX
38.12%
S&P 500 (^GSPC)
20.78%
3-Year Return
RXRX
56.11%
S&P 500 (^GSPC)
69.22%
5-Year Return
RXRX
90.72%
S&P 500 (^GSPC)
72.47%
Earnings Trends
View MoreAnalyst Insights
View MoreStatistics
View MoreValuation Measures
As of 6/23/2026
Market Cap
1.68B
Enterprise Value
1.10B
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
23.03
Price/Book (mrq)
1.64
Enterprise Value/Revenue
16.66
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
0.00%
Return on Assets (ttm)
-27.66%
Return on Equity (ttm)
-57.16%
Revenue (ttm)
66.41M
Net Income Avi to Common (ttm)
-559.78M
Diluted EPS (ttm)
-1.1900
Balance Sheet and Cash Flow
Total Cash (mrq)
654.47M
Total Debt/Equity (mrq)
7.06%
Levered Free Cash Flow (ttm)
-177.8M
Compare
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Company Insights
Fair Value
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected. Learn more
Dividend Score
The distribution of earnings a company pays back to its shareholders based off the company’s profits. Usually paid out on a quarterly basis in the form of cash or additional stocks.
Hiring Score
A company’s hiring trends in key indicators can indicate how well the company is doing in terms of growing the company and where they are currently prioritizing.
Insider Sentiment Score
Vicker’s Insider Sentiment provides insights into trades made by insiders. This can be used to gain valuable insights and as a reflection of the prospect of the company based on insider trading.